扩展性心肌病和心力衰竭是由斯兰本突变引起的
Joachim P Schmitt1, Mitsuhiro Kamisago, Michio Asahi
1Department of Genetics, Harvard Medical School and Howard Hughes Medical Institute, 200 Longwood Avenue, Boston, MA 02115, USA.
概括
福斯福兰班 (PLN) 的遗传性心力衰竭突变扰乱了心肌细胞中的处理. 扩张性心肌病的这一发现可能会导致心力衰竭的新疗法.
科学领域:
- 心脏病学 心脏病学
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- 心力衰竭是一个不断增长的流行病,分子原因不明.
- 扩张性心肌病是一种重要的心力衰竭形式.
研究的目的:
- 为了确定遗传扩张性心肌病的分子原因.
- 了解索兰班突变导致心力衰竭的机制.
主要方法:
- 基因测序用于识别突变.
- 创建转基因小鼠模型,表达突变的索兰班.
- 细胞和生化分析研究蛋白质功能和处理.
主要成果:
- 在斯兰本 (PLN) 中的残留物9 (R9C) 中存在的主导的Arg --> Cys误解突变被确定为遗传扩张性心肌病的原因.
- 转基因小鼠与PLN (R9C) 呈现心力衰竭和过早死亡.
- 突变的PLN(R9C) 蛋白质捕获蛋白激酶A (PKA),防止野生型PLN的酸化,并改变肌细胞过渡物.
结论:
- 肌细胞调节失调,由PLN(R9C) 突变引发,可以导致人体心力衰竭.
- 这一发现通过准处理机制,为心力衰竭开辟了潜在的治疗途径.
相关概念视频
Imbalances in Cardiac Output
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Myocarditis I: Introduction
Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Heart Failure I: Introduction
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
Heart Failure II: Pathophysiology
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Heart Failure III: Clinical Manifestations
Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...


